ENTITY
Shuwozhe®
Shuwozhe®
PulseAugur coverage of Shuwozhe® — every cluster mentioning Shuwozhe® across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
FAA clears SpaceX Starship's 13th test flight; Dizhu Pharma licenses drug to AstraZeneca
The U.S. Federal Aviation Administration (FAA) has concluded its investigation into the anomaly during SpaceX's 12th Starship test flight. The agency has accepted SpaceX's proposed corrective actions, clearing the way f…
-
Hits Medicine licenses Shuwozhe® to AstraZeneca for up to $1.9B plus royalties
Hits Medicine has entered into a licensing agreement with AstraZeneca, granting the global rights to develop and commercialize its drug Shuwozhe®. In return, Hits Medicine will receive an upfront payment of $600 million…